Appointment of Non-Executive Directors
Benchmark strengthens the board bringing in leading industry and commercial expertise
Benchmark today announces the appointment of Hugo Wahnish and Yngve Myhre as Non-Executive Directors of the Company with immediate effect.
Hugo Wahnish has over 35 years of experience in the animal health and pharmaceuticals industry, firstly with GlaxoSmithKline, and more recently with Merck during a period of major growth in the organisation. Hugo held the post of Chief Commercial Officer Animal Health at Merck, having responsibility for Merck’s commercial operations worldwide. Since stepping down from that role in 2012, Hugo has acted as an independent senior advisor with several multinational companies, private equity groups and consulting firms primarily in the animal health sector. Hugo brings a wealth of international experience to the board of Benchmark, alongside his expertise in aggressively growing businesses and in the commercialisation of medicines and animal health products. Hugo is based in the United States.
Yngve Myhre has more than 20 years experience in the aquaculture sector as a senior executive, adviser and investor. Yngve was chief executive of leading Norwegian salmon producer Salmar, and of international white fish supplier Aker Seafood during periods of successful growth. He is now chairman of Chilean salmon producer Nova Austral, and sits on the boards of Mediterranean fish producer Andromeda and Norwegian aquaculture research institute Nofima. Yngve also acts as strategic adviser to investors in the aquaculture sector. Yngve has a very strong track record in Benchmark’s focus area of aquaculture, both in the Norwegian and international markets. Yngve is based in Norway.
We are delighted to welcome Hugo and Yngve to the Board of Benchmark. Their combined expertise and experience in the aquaculture and pharmaceutical industries will broaden the Board of Benchmark as the Company seeks to maximise value from its unique portfolio of products and technologies.
“The Board of Benchmark carried out an extensive international search to bring to the Board additional leading international industry and commercialisation expertise. Attracting Hugo and Yngve is a testament of the strength of our industry standing, our technology platform and our potential.”
This article was corrected on 06 November 2017 it was erroneously stated that Nova Austral is owned by Cargill, and it should have stated that it is owned by Altor and Bain.